These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10879390)

  • 1. Advantages and disadvantages of trial designs: a review of analysis methods for ICD studies. AVID Investigators.
    Hallstrom AP; Anderson JL; Cobb LA; Friedman PL; Herre JM; Klein RC; McAnulty J; Steinberg JS
    Pacing Clin Electrophysiol; 2000 Jun; 23(6):1029-38. PubMed ID: 10879390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of death in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial.
    J Am Coll Cardiol; 1999 Nov; 34(5):1552-9. PubMed ID: 10551706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R
    Am J Cardiol; 1999 Mar; 83(5B):68D-73D. PubMed ID: 10089843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of the AVID and DAVID trials of implantable defibrillators.
    Sharma A; Epstein AE; Herre JM; Klein RC; Platia EV; Wilkoff B; Ledingham RB; Greene HL; Hallstrom AP;
    Am J Cardiol; 2005 Jun; 95(12):1431-5. PubMed ID: 15950565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Over-AVID subgroup analysis.
    Goldberger JJ; Parker MA; Kadish AH
    J Am Coll Cardiol; 2001 Nov; 38(5):1586-7. PubMed ID: 11691549
    [No Abstract]   [Full Text] [Related]  

  • 6. Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.
    Tsai CT; Huang SK; Lin JL; Lai LP;
    Pacing Clin Electrophysiol; 2003 Nov; 26(11):2083-90. PubMed ID: 14622308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The AVID trial: evidence based or randomized control trials--is the AVID study too late? Antiarrhythmics Versus Implantable Defibrillators.
    Josephson ME; Nisam S
    Am J Cardiol; 1997 Jul; 80(2):194-7. PubMed ID: 9230158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of the implantable cardioverter defibrillator secondary prevention trials. AVID, CASH and CIDS studies. Antiarrhythmics vs Implantable Defibrillator study. Cardiac Arrest Study Hamburg . Canadian Implantable Defibrillator Study.
    Connolly SJ; Hallstrom AP; Cappato R; Schron EB; Kuck KH; Zipes DP; Greene HL; Boczor S; Domanski M; Follmann D; Gent M; Roberts RS
    Eur Heart J; 2000 Dec; 21(24):2071-8. PubMed ID: 11102258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of clinical characteristics and frequency of implantable defibrillator use between randomized patients in the Antiarrhythmics Vs Implantable Defibrillators (AVID) trial and nonrandomized registry patients.
    Kim SG; Hallstrom A; Love JC; Rosenberg Y; Powell J; Roth J; Brodsky M; Moore R; Wilkoff B
    Am J Cardiol; 1997 Aug; 80(4):454-7. PubMed ID: 9285657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Are implantable cardioverter-defibrillators or drugs more effective in prolonging life? The Antiarrhythmics Versus Implantable Defibrillators (AVID) Trial Executive Committee.
    Am J Cardiol; 1997 Mar; 79(5):661-3. PubMed ID: 9068527
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale and design of the PRAETORIAN trial: a Prospective, RAndomizEd comparison of subcuTaneOus and tRansvenous ImplANtable cardioverter-defibrillator therapy.
    Olde Nordkamp LR; Knops RE; Bardy GH; Blaauw Y; Boersma LV; Bos JS; Delnoy PP; van Dessel PF; Driessen AH; de Groot JR; Herrman JP; Jordaens LJ; Kooiman KM; Maass AH; Meine M; Mizusawa Y; Molhoek SG; van Opstal J; Tijssen JG; Wilde AA
    Am Heart J; 2012 May; 163(5):753-760.e2. PubMed ID: 22607851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical criteria for predicting benefit of ICD/PM in post myocardial infarction patients: an AVID and CAST analysis.
    Hallstrom AP; Wyse DG; McAnulty J; ;
    J Interv Card Electrophysiol; 2008 Dec; 23(3):159-66. PubMed ID: 18810620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patients at lower risk of arrhythmia recurrence: a subgroup in whom implantable defibrillators may not offer benefit. Antiarrhythmics Versus Implantable Defibrillator (AVID) Trial Investigators.
    Hallstrom AP; McAnulty JH; Wilkoff BL; Follmann D; Raitt MH; Carlson MD; Gillis AM; Shih HT; Powell JL; Duff H; Halperin BD;
    J Am Coll Cardiol; 2001 Mar; 37(4):1093-9. PubMed ID: 11263614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of the implantable defibrillator on mortality: the axiom of overall implantable cardioverter-defibrillator survival.
    Fogoros RN
    Am J Cardiol; 1996 Sep; 78(5A):57-61. PubMed ID: 8820837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiarrhythmic drugs versus implantable defibrillators: the need for a randomized controlled study.
    Greene HL
    Am Heart J; 1994 Apr; 127(4 Pt 2):1171-8. PubMed ID: 8160597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "An AVID dissent": commentary.
    Connolly SJ
    Pacing Clin Electrophysiol; 1994 Nov; 17(11 Pt 1):1712-3. PubMed ID: 7838778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
    Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
    Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Why the antiarrhythmics versus implantable defibrillator (AVID) trial sets the wrong precedent.
    Fogoros RN
    Am J Cardiol; 1997 Sep; 80(6):762-5. PubMed ID: 9315584
    [No Abstract]   [Full Text] [Related]  

  • 20. Implantable defibrillators for the prevention of mortality in patients with nonischemic cardiomyopathy: a meta-analysis of randomized controlled trials.
    Desai AS; Fang JC; Maisel WH; Baughman KL
    JAMA; 2004 Dec; 292(23):2874-9. PubMed ID: 15598919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.